Together, these observations provide a mechanistic rationale for IFN-I–targeted therapies in photosensitive autoimmunity and identify MMP9+ monocyte-derived dendritic cells as a tractable, disease-relevant cellular target. The gene discussed is MMP9; the disease is Autoimmunity.